EPIRUS Biopharmaceuticals, Inc. Notes Payable, Current
EPIRUS Biopharmaceuticals, Inc. had Notes Payable, Current of $6.50 million as of 2012-12-31, per its 10-K filed 2013-03-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2013-03-07
- 2012-12-31: Notes Payable, Current $6.50M.
| Period end | Notes Payable, Current |
|---|---|
| 2012-12-31 | $6.50M 10-K · filed 2013-03-07 |